UBS Group »

Regentis Biomaterials shares owned by UBS Group

Quarter-by-quarter ownership of Regentis Biomaterials (RGNT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Regentis Biomaterials

Tip: Access up to 7 years of quarterly data

All positions including Regentis Biomaterials held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regentis Biomaterials by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0k 334 3.05

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Regentis Biomaterials

AIGH Capital Management
Rosalind Advisors
UBS Group

View all funds holding Regentis Biomaterials